Free Trial

Starr Indemnity & Liability Co Takes Position in Bain Capital Specialty Finance, Inc. (NYSE:BCSF)

Bain Capital Specialty Finance logo with Finance background

Starr Indemnity & Liability Co bought a new stake in Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 598,001 shares of the company's stock, valued at approximately $10,477,000. Bain Capital Specialty Finance comprises approximately 5.2% of Starr Indemnity & Liability Co's portfolio, making the stock its 5th largest position. Starr Indemnity & Liability Co owned about 0.93% of Bain Capital Specialty Finance as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Mascoma Wealth Management LLC purchased a new position in shares of Bain Capital Specialty Finance in the fourth quarter valued at about $29,000. Quantbot Technologies LP bought a new position in Bain Capital Specialty Finance during the 3rd quarter valued at approximately $136,000. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Bain Capital Specialty Finance in the 4th quarter worth approximately $151,000. Centiva Capital LP bought a new stake in shares of Bain Capital Specialty Finance in the 3rd quarter worth approximately $199,000. Finally, Cooper Financial Group increased its stake in shares of Bain Capital Specialty Finance by 7.5% during the fourth quarter. Cooper Financial Group now owns 15,064 shares of the company's stock valued at $264,000 after buying an additional 1,053 shares during the period.

Bain Capital Specialty Finance Stock Down 6.6 %

Shares of BCSF stock traded down $1.07 during mid-day trading on Friday, reaching $15.16. 840,723 shares of the company's stock traded hands, compared to its average volume of 241,818. The company's 50-day moving average price is $17.57 and its 200-day moving average price is $17.21. The company has a market cap of $979.82 million, a P/E ratio of 7.62 and a beta of 0.79. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 1.13. Bain Capital Specialty Finance, Inc. has a 12 month low of $14.65 and a 12 month high of $19.21.

Bain Capital Specialty Finance (NYSE:BCSF - Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.49 by $0.03. The business had revenue of $73.30 million for the quarter, compared to the consensus estimate of $67.50 million. Bain Capital Specialty Finance had a return on equity of 11.90% and a net margin of 43.62%. On average, equities analysts expect that Bain Capital Specialty Finance, Inc. will post 2.06 earnings per share for the current fiscal year.

Bain Capital Specialty Finance Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Tuesday, December 16th will be issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.79%. The ex-dividend date of this dividend is Tuesday, December 16th. Bain Capital Specialty Finance's payout ratio is 90.81%.

Insider Activity

In related news, Director Clare Stack Richer bought 1,530 shares of the firm's stock in a transaction that occurred on Monday, March 17th. The shares were bought at an average cost of $16.43 per share, with a total value of $25,137.90. Following the acquisition, the director now owns 20,835 shares in the company, valued at $342,319.05. This trade represents a 7.93 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.59% of the company's stock.

Analyst Ratings Changes

Several research analysts have commented on the stock. Keefe, Bruyette & Woods upped their price objective on shares of Bain Capital Specialty Finance from $17.00 to $18.00 and gave the stock a "market perform" rating in a report on Tuesday, March 4th. Wells Fargo & Company raised their price objective on shares of Bain Capital Specialty Finance from $18.00 to $19.00 and gave the stock an "overweight" rating in a report on Monday, March 3rd.

Read Our Latest Stock Analysis on BCSF

Bain Capital Specialty Finance Company Profile

(Free Report)

Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.

See Also

Institutional Ownership by Quarter for Bain Capital Specialty Finance (NYSE:BCSF)

Should You Invest $1,000 in Bain Capital Specialty Finance Right Now?

Before you consider Bain Capital Specialty Finance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bain Capital Specialty Finance wasn't on the list.

While Bain Capital Specialty Finance currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines